Healthcare Equity Angels

Founder and Managing Director Jack Topdjian leads deal evaluation, supported by a member network of healthcare executives. Members such as Elizabeth Haar and Wendy Sherry contribute domain-specific diligence rather than voting as a formal investment committee. The group operates on a deal-by-deal syndication model, meaning individual angels make their own capital commitment decisions.

Deal flow is channeled primarily through the Keiretsu Forum syndication network, where HEA is an active partner. Topdjian's additional role as a Venture Partner at SmartGateVC provides a secondary pipeline, linking the group to venture-backed health-tech startups seeking clinical and operational validation from experienced healthcare angels.

No. It operates as an angel group, not a pooled venture fund. Members invest their own capital on a per-deal basis through syndicated special-purpose vehicles. There is no blind pool, no management fee, and no publicly disclosed fund vehicle.

The group focuses on early-stage health-tech companies, covering seed and start-up rounds. Its operator-heavy membership aligns with companies that have progressed beyond concept stage and are navigating clinical pilots, regulatory milestones, or early commercial traction in healthcare.

Digital health, healthcare services, and health-tech broadly. The membership's operating backgrounds in health insurance, workers' compensation, and benefits administration suggest a practical tilt toward companies solving payer, provider, or employer-facing workflow and access problems.